Vicki Singer, Ph.D., President and Chief Executive Officer
Dr. Singer has nearly 30 years’ life science industry experience leading business segments, strategy, marketing, business development and research and development teams. She has served as Vice President and Head of Technology Strategy for Life Technologies (LIFE) and Thermo Fisher Scientific, as Global Head of Out Licensing for LIFE, Business Segment Director for the Labeling & Detection (Molecular Probes) business of Invitrogen, as Business Development Director for Invitrogen and Molecular Probes, and formed and led the Molecular Biology R&D team at Molecular Probes. Dr. Singer holds a Ph.D. in Biochemistry from UC Berkeley and performed postdoctoral studies at Harvard Medical School.
Bill Jackson, Ph.D., Founder and Chief Scientist
Dr. Jackson has served as Principal Investigator on over $5M in Small Business and Innovation Reseasrch grants. Dr. Jackson is also a recognized leader in the aptamer space having authored twelve peer-reviewed publications on aptamers as well as 50+ posters and conference proceedings. In 2010 he co-authored the first market research report on aptamers. Dr. Jackson is inventor on twelve issued U.S. patents (and many corresponding international filings) as well as numerous patents pending. Dr. Jackson holds a B.S. in biomedical engineering and a B.A. in Spanish literature from Texas A&M University and a Ph.D. in chemical engineering from the University of Houston.
Rob Batchelor, M.S., Director of Aptamer Development
Rob has more than 16 years of product and assay development and scientific team leadership experience. He led or participated in the development of more than fifty products while at Molecular Probes, Invitrogen, Life Technologies, and Marker Gene Technologies. He has extensive experience in the optimization of fluorescence-based assays. Rob received a B.S. in Biochemistry and an M.S. in Pharmacology from the University of Washington – Seattle.
Christopher Quan, Esq., General Counsel
Christopher has more than 12 years of experience working in intellectual property and legal segments in biotechnology, dental and engineering small companies with extensive work in patent prosecution, research and development practices and intellectual property licensing. Christopher holds a B.S. in biomedical engineering from the University of Rochester and a J.D. from the University of Houston. He is a registered U.S. patent attorney and is admitted to the bar in Texas.
Amy Willson, Senior Manager, Marketing
Amy has 25 years of product development, product management and marketing management experience in the biotechnology industry. She has successfully launched and supported instrumentation, software, and reagents with companies including Pierce Biotechnology, Thermo Fisher Scientific, Aushon BioSystems, Nexcelom, and Mettler-Toledo Process Analytics. Amy holds bachelor’s degrees in Biochemistry and Political Science from Boston College and will be earning her M.B.A. from the University of New Hampshire this May.